Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune pathogenesis and autoimmune hemolytic anemia.

John W Semple1, John Freedman

  • 1Department of Laboratory Medicine, St. Micheal's Hospital, University of Toronto, Ontario, Canada. semplej@smh.toronto.on.ca

Seminars in Hematology
|July 26, 2005
PubMed
Summary

Autoimmune hemolytic anemia (AIHA) involves autoantibodies attacking red blood cells (RBCs). This review explores the immunopathogenic mechanisms behind autoantibody production in AIHA, crucial for developing targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding immune thrombocytopenia pathophysiology has come a long way.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Toggling STAT to restore T-cell homeostasis in ITP.

Blood·2026
Same author

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia.

British journal of haematology·2026
Same author

Circulating T follicular helper cells as emerging biomarkers in pediatric Evans syndrome.

Haematologica·2026
Same author

Platelet transcriptomics sense disease states.

EBioMedicine·2026
Same author

Platelet glycoprotein V autoantibodies and complement C3 are associated with thrombosis in systemic lupus erythematosus.

Haematologica·2026

Area of Science:

  • Immunology
  • Hematology
  • Autoimmunity

Background:

  • Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies targeting red blood cells (RBCs).
  • RBC clearance is enhanced via Fc receptor (FcR)-mediated phagocytosis.
  • Limited research exists on the production of IgG autoantibodies against RBC autoantigens.

Purpose of the Study:

  • To review general autoimmunity.
  • To elucidate the immunopathogenic mechanisms of autoantibody production in AIHA.
  • To highlight the importance of understanding these mechanisms for novel immunotherapies.

Main Methods:

  • Review of existing literature on AIHA.
  • Discussion of human and animal studies.
  • Focus on immunopathogenic mechanisms of autoantibody generation.

Related Experiment Videos

Main Results:

  • General principles of autoimmunity are discussed.
  • Current knowledge on AIHA-specific autoantibody production is presented.
  • Mechanisms involving autoantibodies and RBCs are detailed.

Conclusions:

  • Understanding AIHA pathogenesis is critical.
  • Elucidating autoantibody production pathways is key.
  • This knowledge is vital for developing antigen-specific immunotherapies for AIHA.